A detailed history of Williamson Legacy Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Williamson Legacy Group, LLC holds 56,674 shares of LLY stock, worth $42.8 Million. This represents 33.56% of its overall portfolio holdings.

Number of Shares
56,674
Previous 42,980 31.86%
Holding current value
$42.8 Million
Previous $38.9 Billion 29.03%
% of portfolio
33.56%
Previous 28.95%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $10.6 Million - $13.1 Million
13,694 Added 31.86%
56,674 $50.2 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $73,211 - $91,813
101 Added 0.24%
42,980 $38.9 Billion
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $61,588 - $82,397
-104 Reduced 0.24%
42,879 $33.4 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $22.6 Million - $26.6 Million
42,983 New
42,983 $25.1 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Williamson Legacy Group, LLC Portfolio

Follow Williamson Legacy Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Williamson Legacy Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Williamson Legacy Group, LLC with notifications on news.